Acute Myeloid Leukemia Without Maturation
📧 Sign up to get email alerts when something new happens for Acute Myeloid Leukemia Without Maturation.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia [Phase 2]
A Phase 2 clinical trial evaluating the combination of decitabine, cytarabine, and daunorubicin hydrochloride for treatment of Acute Myeloid…
-
CLINICAL_TRIALS research · 2016-12-06Clinical Trial Update: CAR-pNK Cell Immunotherapy for Relapsed/Refractory CD33+ AML [Phase 1, Phase 2]
This entry reports a clinical trial update for CAR-pNK cell immunotherapy in relapsed/refractory CD33+ acute myeloid leukemia. The trial spa…
-
CLINICAL_TRIALS trial_result · 2015-08-20Clinical Trial Update: Azacitidine, Mitoxantrone Hydrochloride, and Etoposide in Treating Older Patients With Poor-Prognosis Acute Myeloid Leukemia [Phase 1]
A Phase 1 study evaluating a combination of azacitidine, mitoxantrone hydrochloride, and etoposide in older patients with poor-prognosis acu…
-
CLINICAL_TRIALS trial_result · 2015-06-19Clinical Trial Update: Cholecalciferol in Treating Patients With Acute Myeloid Leukemia Undergoing Intensive Induction Chemotherapy [Phase 2]
Phase 2 trial evaluating cholecalciferol (Vitamin D3) in adults with acute myeloid leukemia undergoing intensive induction chemotherapy; the…
-
CLINICAL_TRIALS trial_result · 2013-09-19Clinical Trial Update: Entinostat and Sorafenib Tosylate in Treating Patients With Advanced or Metastatic Solid Tumors or Refractory or Relapsed Acute Myeloid Leukemia [Phase 1]
A Phase 1 trial evaluating the combination of entinostat and sorafenib in patients with advanced or metastatic solid tumors or relapsed/refr…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.